Division 1.2.6
United Kingdom
Quinolones
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Decoquinate | Decoquinate | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 500 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| Enrofloxacin | Sum of enrofloxacin and ciprofloxacin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
| 100 μg/kg | Fat | ||||
| 300 μg/kg | Liver | ||||
| 200 μg/kg | Kidney | ||||
| Flumequine | Flumequine | Bovine, ovine, porcine, chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 50 μg/kg | Fat or skin and fat | ||||
| 100 μg/kg | Liver | ||||
| 300 μg/kg | Kidney | ||||
| Salmonidae | 150 μg/kg | Muscle and skin | |||
| Marbofloxacin | Marbofloxacin | Bovine | 150 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 50 μg/kg | Fat | ||||
| 150 μg/kg | Liver | ||||
| 150 μg/kg | Kidney | ||||
| 75 μg/kg | Milk | ||||
| Porcine | 150 μg/kg | Muscle | |||
| 50 μg/kg | Skin and fat | ||||
| 150 μg/kg | Liver | ||||
| 150 μg/kg | Kidney |